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lowed by stenting in 22/26 (85%). Within median 5 days (range 0-14), 11/26 (42%) under-
went reoperative mitral (n=8) or aortic (n=3) valve surgery. The remaining 15 patients
underwent primary mitral (n=13), aortic (n=1) or double (n=1) valve surgery. Concomitant
CABG was performed to non-stented (non culprit) vessels in 9 primary mitral and 1 aortic
valve patients. Operative mortality was 3.8% (1/26). Survival at 1, 3 and 5 years was
78%, 56% and 44% respectively.
Conclusion: “Hybrid” initial PCI followed by staged valve surgery may represent an alter-
native to conventional valve/CABG in some high-risk patients, particularly those who
present in shock after myocardial infarction and some patients who require reoperative
valve surgery.
2:45 p.m.
851-4 Changing Outlook After Aortic Valve Surgery for 
Chronic Aortic Regurgitation With Severe Left 
Ventricular Dysfunction
Sunil K. Bhudia, Patrick M. McCarthy, Ganesh S. Kumpati, Katherine J. Hoercher, 
Jeevanantham Rajeswaran, Eugene H. Blackstone, The Cleveland Clinic Foundation, 
Cleveland, OH
Background: Historically, patients (pts) with chronic aortic regurgitation (AR) and severe
left ventricular (LV) dysfunction have been considered for transplant due to perceived
high operative mortality after aortic valve (AV) surgery and limited late survival. We
sought to determine change in hospital mortality over time, late survival compared with
pts without severe LV dysfunction, and risk factors for death after AV surgery.
Methods: From 1972 to 1999, 724 pts underwent AV surgery for chronic (>3 mo) AR; 88
(12%) had severe LV dysfunction (ejection fraction <30%). They were propensity
matched to pts with non-severe LV dysfunction to compare hospital mortality and time-
related survival. Propensity score adjusted multivariable analysis of all 724 pts was per-
formed to identify risk factors for death.
Results: Hospital mortality in pts with severe LV dysfunction has fallen to 0% (0/35) since
1985, comparable to that of propensity-matched pts with non-severe LV dysfunction
(Fig). Time-related survival in pts operated on from 1985 to 1999 was similar in both
groups (P=.96) and comparable to that of transplantation. Risk factors for death included
earlier date of surgery and severe LV dysfunction, but not interaction between them
(P=.5).
Conclusions: AV surgery in pts with severe LV dysfunction is no longer a futile, high-risk
procedure for which transplantation is the only option. Neutralization of severe LV dys-
function has been accomplished by across-the-board improvement in early results of AV
surgery. 
3:00 p.m.
851-5 Hemodynamic Response to Inhaled Nitric Oxide in 
Adult Cardiac Surgery
Frank D. Wagner, Tom Gromann, Deutsches Herzzentrum Berlin, Berlin, Germany
Background: Inhaled nitric oxide (iNO) has been established as a selective pulmonary
vasodilator in the treatment of pulmonary hypertension associated with acute right ven-
tricular (RV) failure. This study reviews our single-center experience with the use of iNO
in adult cardiac surgery.
Methods: We retrospectively evaluated 600 patients (mean age 55±16 years; 408 male,
192 female) treated postoperatively with iNO between 1997 and 2002. Patients pre-
sented with acute pulmonary hypertension after heart transplantation HTx (n=164),
CABG (n=115), left ventricular assist device (LVAD) implantation (n=82), lung transplan-
tation (n=54), mitral valve replacement (n=39), pulmonary thromboendarterectomy
(n=26) and other operations (n=62), and were treated with NO inhalation initiated on
weaning from cardiopulmonary bypass. Hemodynamic parameters were measured prior
to iNO, at 1, 2, 6, 12, 24 and 48 hours during iNO therapy and after weaning from iNO.
Rebound pulmonary hypertension was prevented by slow weaning.
Results: Prior to iNO PVR, mean PAP and CO for the whole group were 242±140
dynesxsxcm-5, 28±10 mmHg and 5.1±1.7 L/min resp., with high inotropic support (epi-
nephrine 0.24±0.16 µg/kg/min). At 6 hours after institution of iNO (mean dose 18±13
ppm) PVR and mean PAP decreased (135±113 dynesxsxcm-5 and 26±9 mmHg
(p<0.0001) and CO increased (5.7±1.7 L/min (p<0.0001). Hemodynamics improved fur-
ther within 48 hours and the epinephrine dose was progressively reduced (p<0.0001).
Patients were weaned from iNO within 32±35 hours. Irrespective of the etiology of pulmo-
nary hypertension the pulmonary vasodilating effect of iNO was proportional to the mean
PAP prior to therapy, whereas the resultant increase in CO was dependent on the extent
of RV dysfunction. Hemodynamic improvement was more pronounced after LVAD
implantation and HTx than after other operations.
Conclusion: In patients presenting with acute pulmonary hypertension after cardiac sur-
gery iNO selectively reduced right ventricular afterload, thereby effectively improving car-
diac output. Beneficial hemodynamic effects of iNO were dependent on the degree of RV
dysfunction and more pronounced after LVAD implantation and HTx.
3:15 p.m.
851-6 Diffusion Weighted Magnetic Resonance Imaging and 
Neurocognitive Outcomes in Atherosclerotic Patients 
Undergoing Off-Pump Coronary Artery Bypass Surgery
Ehtasham A. Qureshi, Adnan Siddiqui, Khalid M. Zirvi, Karthik Linganathan, Francis 
Sutter, Bruce Caplan, Andrew J. Curtin, Amid Khan, Naushad Shaikh, Gary Friday, 
James F. Burke, The Lankenau Hospital and Research Institute, Wynnewood, PA
Background: Reports of neuro-cognitive deficits following off-pump coronary artery
bypass surgery (OPCABG) are conflicting.These deficits, thought to be secondary to
brain ischemia, have not been evaluated using diffusion-weighted magnetic resonance
imaging (DW-MRI), a sensitive method to detect new ischemic lesions.
Methods: Neurocognitive outcomes were assessed in 17 random patients, mean age 70
± 16 (88% males) undergoing OPCABG. Brain DW-MRI was performed before and after
OPCABG in all patients and evaluated for new ischemic lesions by a neuroradiologist
blinded to the clinical data. All patients were assessed and scored for neuropsychological
impairment by the consensus of two independent neurologists using the standard
National Institute of Health Stroke Scale (NIHSS) and a battery of neurocognitive tests
both before and after the surgery.
Results: New focal lesions were seen in 6 (33%) patients, 4 of these were also found to
have neurocognitive decline as assessed by neuropsychological testing. The clinical and
procedural characteristics were similar in patients with and without new DW-MRI
changes. There was no evidence of definitive clinical stroke, as defined by the NIHSS, in
any patient. No patient had pre-operative atrial fibrillation and 4 (23%) developed atrial
fibrillation after OPCABG; none of these patients had any new ischemic lesions on DW-
MRI.
Conclusions: This study suggests that in patients undergoing OPCABG, ischemic brain
lesions occur frequently and factors other than cardiopulmonary bypass maybe impli-
cated for these findings. Further studies with larger number of patients are needed to
determine the clinical significance, predictors and long-term outcome of brain ischemia
following OPCABG.
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1162-135 Intravenous Wafarin Sodium for Anticoagulation After 
Valve Replacement Surgery
Jerome B. Riebman, Thomas Wentzein, Catherine Weirshauser, Michael Nathanson, 
Santa Clara Valley Medical Center, San Jose, CA
BACKGROUND – After valve surgery, oral wafarin sodium (WS) anticoagulation therapy
is delayed due to postoperative coagulopathy and impaired oral medication absorption.
We evaluated the impact of combining initial intravenous wafarin (IVW) therapy during the
first 24 hours postoperatively with traditional postoperative oral WS therapy.
METHODS - Adults (n=22, age 53.8±2.9 mean±SEM, 12 males) undergoing mechanical
valve implantation received 1-2 doses of IVW postoperatively and after 24-48 hours were
continued on oral WS. IVW (2.5-5 mg) was given the night of surgery or the following
morning (POD#0). A second dose of IVW (2.5-7.5 mg) was given during the second 24
hrs (POD#1) if the patient still was not tolerating oral intake. Subsequent daily oral WS
was given in the evenings, and titrated to an INR between 2.0-3.0. Patients were followed
until POD#14 or hospital discharge. A sex and age matched cohort of valve patients
(n=22, age 52.7±2.5, 12 males) receiving standard oral WS served as a comparison pop-
ulation.
RESULTS – Both groups were similar in medical history, operative variables, transfusion
requirements, thoracic drainage, and outcomes. The study patients received a total mean
dose of 8mg IVW followed by daily oral WS dosing. Cohort patients started oral WS
POD#1 or after. Patients receiving IVW followed by oral WS reached therapeutic INR in
3.4±0.42 days compared to 4.9±0.28 days for oral WS only patients (P<0.05).
CONCLUSION – Early postoperative IVW was not associated with negative clinical
events. Patients receiving initial IVW then oral WS reached therapeutic INR more quickly
than patients receiving oral WS only. Safe, earlier anticoagulation can be accomplished
with combination therapy, and may translate in to reductions of hospital stay and costs.
1162-136 Durability and Outcomes of Mitral Valve Repair for 
Infective Endocarditis
Yukikatzu Okada, Ko Bando, Hitoshi Kasegawa, Kobe City General Hospital, Kobe, 
Japan, National Cardiovascular Center, Osaka, Japan
Background: Mitral valve (MV) repair over replacement has significant advantages for
patients with infective endocarditis (IE). However, the durability and late outcome of MV
repair for IE remains to be determined. We sought to determine the risks for mortality,












reoperation, and stroke following MV repair (n=168, 18/168: male, mean age of 47.7
years old) between 1/91 and 12/02.
Methods: Early and late mortality, stroke, and freedom from re-operation were
assessed. Potential predictors of mortality, stroke and re-operation were entered into a
Cox regression model. Actuarial survival, freedom from stroke and freedom from reoper-
ation were determined by a log-rank test.
Results: Kaplan-Meyer estimates for survival, freedom from stroke and freedom from re-
operation at 10 years after MV repair were 92.6 ± 3.9 %, 84.8 ± 4.9 %, and 93.8± 2.3 %
respectively. Cox regression risk (RR) and 95% CI for predictors of late mortality was pre-
op stroke within 14 days prior to surgery: RR 1.81(1.06-2.76). Cox regression risk (RR)
and 95% CI for predictors of late stroke was late AF: RR 18.3 (6.8-49.3). Risks for re-
operation included pre-op NYHA class IV: RR 4.9 (1.1-21.8) and extended endocarditis
over one third of each leaflet: RR 2.3 (0.5-11.9). No patients required reoperation for sus-
tained or recurrent infection.
Conclusion: These results indicated that MV repair for MV endocarditis provided excel-
lent survival, freedom reoperation and freedom from re-infection with long-term durability
of repaired valves. Only pre-op stroke within 2 weeks before surgery predicted late mor-
tality.
1162-137 Valve Surgery in Octogenarians: In-Hospital and Long-
Term Outcomes
Eduardo Bossone, Alessandro Frigiola, Giuseppe Di Benedetto, Silvia Cirri, Antonello 
Panza, Andrea Ballotta, Paolo Righini, Gianniignazio L. Carbone, Jianming Fang, 
Alessandro Distante, Kim A. Eagle, Rajendra H. Mehta, National Research Institute, 
Lecce, Italy, University of Michigan, Ann Arbor, MI
Background: The aging of global population and the higher incidence of ischemic,
degenerative and calcific valve disease with advancing age have resulted in more octo-
generians being referred for valve surgery. However, the pre-operative risk factors and
the hospital and long-term outcomes in this age group are less known.
Methods: We evaluated 307 consecutive patients age >80 years undergoing valve sur-
gery at 3 major Italian cardiac centers (age 83±2.4 yrs, females=60%). Majority of
patients had aortic valve surgery (AVS) either alone (n=134) or with CABG (n=94), aortic
surgery (n=3) or mitral valve surgery (MVS, n=26). The remaining patients underwent
MVS alone or with CABG or tricuspid valve repair.
Results: Most common hospital complications included atrial arrhythmias (50%), need
for inotropic support >48 hours (37%), renal insufficiency (28%), congestive heart failure
(23%), respiratory failure (22%), and stroke (6%). Death at 30-day occurred in 30
patients (9.7 %). Multivariate logistic regression identified: NYHA class IV (OR=5.2, 95%
CI=1.9-14.0; p=0.001); diabetes (OR=2.8, 95% CI=1.1-7.1; p=0.027); hypertension
(OR=3.7, 95% CI=1.2-11; p=0.025); renal insufficiency at presentation (OR=3.4, 95%
CI=1.2-9.4; p=0.022); rheumatic etiology (OR=3.8, 95% CI=1.1-12.9; p=0.030) and left
ventricular ejection fraction <45% (OR=6.2, 95% CI=1.1-35.3; p=0.041) as predictors of
hospital death. At follow-up (42±30 months, range=1-134 months), there were 45 more
deaths. Mortality was highest in patients undergoing MVS combined with other valve sur-
gery or CABG (21.6%). However, among long term survivors (n=232), the NYHA class
improved between pre- (3.0+0.7) to post-operative (1.7+0.6) periods (p<0.0001).
Conclusions: For selected symptomatic octogenarians with valve disease, surgery may
be an effective therapeutic option associated with good long-term survival and improve-
ment in functional class. The risk predictors of hospital death among these patients iden-
tified in our study may help physicians while counseling patients and their families to
make them understand their risk of valve surgery.
1162-138 Should Patients With Severe Aortic Stenosis and 
Coronary Artery Disease Undergoing Percutaneous 
Coronary Intervention Prior to Aortic Valve 
Replacement?
Pramod K. Kuchulakanti, Seung-Woon Rha, Natalie Gevorkian, Maureen C. Abbott, 
Augusto D. Pichard, Lowell F. Satler, Kenneth M. Kent, William O. Suddath, Ron 
Waksman, Washington Hospital Center, Washington, DC
Background: Symptomatic severe valvular aortic stenosis (defined as echocardio-
graphic valve area<0.75cm2, peak velocity>4m/sec or peak instantaneous gradient of
>75mmHg) frequently co-exists with coronary artery disease (CAD). The recommended
strategy is aortic valve replacement (AVR) with aorto coronary bypass surgery (CABG).
We undertook a study to examine the outcome of percutaneous coronary intervention
(PCI) alone in patients who could not undergo AVR.
Methods: A retrospective analysis of the medical records of patients with aortic valve
disease who underwent PCI at Washington Hospital Center was conducted. The patients
were divided into two groups: PCI without AVR (Gp 1, n=28) and PCI with AVR (Gp 2,
n=55). The procedural complications, in-hospital course and 1-year clinical outcomes
were compared.
Results: Clinical characteristics were comparable except that patients in Gp 1 were eld-
erly (78.8±8.8 vs.68.8±9.4 years, p <0.001) and had more renal insufficiency (28.6% vs.
10.9%, p=0.04). Gp 1 patients had less coronary bypass grafts compared to Gp 2 (35.7%
vs. 58.2%, p=0.05). Procedural characteristics and post procedure complications were
similar. Post procedural CPK-MB elevation was significantly higher in Gp 1(28.6% vs.9.8
%, p=0.03). At 6 months and 1 year follow-up, patients in Gp 1 had more non-Q-wave
myocardial infarctions and mortality due to out of hospital events.
Conclusions: Patients with CAD and severe AS should not undergo PCI alone prior to
AVR.
1162-139 Ablation of Atrial Fibrillation as a Concomitant Cardiac 
Surgical Procedure: Clinical Results
Mark J. Cunningham, Becky Lopez, Mark L. Barr, Vaughn A. Starnes, Keck School of 
Medicine University of Southern California, Los Angeles, CA
Background: Surgical radiofrequency ablation of atrial fibrillation (AF) has become an
accepted practice. This study reviewed outcome data to evaluate its relationship to free-
dom from AF.
Methods: Patients with AF underwent surgical ablation as a concomitant cardiac proce-
dure. Ablation lesions were created with unipolar and/or bipolar radiofrequency instru-
ments. Both epicardial and endocardial approaches were used on the arrested or beating
heart via sternotomy. Lesion sets included isolation of the pulmonary veins, excision or
exclusion of the left atrial appendage, and serial ablation lines consistent with the modi-
fied Cox-maze procedure.
Results: Over 2.5 years, 30 consecutive patients underwent surgical ablation of atrial
fibrillation at our institution. 23 patients had persistent AF and 7 had paroxysmal AF. The
patient population had a mean age of 62±12 years (range 36-78), was 50% male and
50% female, with a mean LA diameter of 51±7mm, and a mean ejection fraction of
53±9%. Actuarial freedom from AF was 77% at the most recent visit with a mean follow-
up of 10±8 months.
Conclusion: Surgical ablation of AF using the radiofrequency ablation technique is safe
and effective to eliminate atrial fibrillation in 77% of patients. Increased age and moder-
ately reduced EF are associated with inferior success rates.
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868-1 Increased Tricuspid Regurgitation in Patients With 
Pulmonary Hypertension When Left Ventricular 
Dysfunction Is Present: A New Mechanism of 
Malcoaptation
Mordehay Vaturi, Judy Hung, Robert A. Levine, Massachusetts General Hospital, 
Boston, MA
Background: Tricuspid regurgitation (TR) alters prognosis in heart failure with pulmo-
nary hypertension (PHTN). Clinically, we observed more frequent and severe TR when
PHTN was associated with LV dysfunction (LVDys). Database review of 2,326 patients
(pts) with PHTN>50 mmHg confirmed moderate to severe TR in 63% with LVDys vs 43%
without it (p<.001). We explored whether this reflects differences in TR mechanism with
altered LV and septal geometry. Methods: 2D echoes were reviewed in 39 pts with
severe PHTN (70-100), 14 with normal LV and 25 with LVDys (EF=72±4 vs 23±5%).
Results: Pts with LVDys had higher prevalence of moderate and severe TR (72% vs
36%, p=.02) despite smaller RV end-diastolic area (4-chamber: 20±6 vs 26±8 cm2,
p=.04) and lower RV systolic pressure (75±5 vs 89±11, p<.001). % RV area change,
annular diameter, and apical leaflet tenting area were not different. Eccentric TR jets
were common in LVDys (68 vs 7%, p=.001), with the anterior leaflet buckling superior to
a more apically restricted septal leaflet. This accompanied LV bulging into the RV, partic-
ularly in 13/14 with septal akinesis. These differences persisted after matching pts for RV
pressure (average 76). Conclusion: In comparable degrees of PHTN, TR is more severe
with LVDys, with frequently eccentric jets indicating malcoaptation. This is associated







Death in hospital 3.6% 3.6% 0.98
6 months Non-Q-wave MI 35.0% 11.9% 0.03
Death out of hospital 28.6% 7.0% 0.020
1 year Non-Q-wave MI 46.7% 12.8% 0.007
Death out of hospital 45.0% 9.8% 0.002
